These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3025927)

  • 1. Neuropeptides: ACTH-peptides in dementia.
    Kragh-Sørensen P; Olsen RB; Lund S; Van Riezen H; Steffensen K
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):479-92. PubMed ID: 3025927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of synthetic neuropeptides in psycho-organic brain syndrome. Results with ACTH4-10 and ACTH4-9-analog (author's transl)].
    Schneider E; Jacobi P; van Riezen H; Voerman JW; Fischer PA
    Pharmacopsychiatria; 1981 Sep; 14(5):155-9. PubMed ID: 6270708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACTH 4-9 analogue (Org 2766) in depressed elderly patients. I. Effect on depressed mood.
    Frederiksen SO; d'Elia G; Bengtsson BO
    Acta Psychiatr Scand; 1985 Oct; 72(4):341-8. PubMed ID: 3000138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a synthetic peptide, ORG 2766, on inpatients with severe senile dementia. A controlled clinical trial.
    Martin JC; Ballinger BR; Cockram LL; McPherson FM; Pigache RM; Tregaskis D
    Acta Psychiatr Scand; 1983 Mar; 67(3):205-7. PubMed ID: 6305110
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurotrophic effects of ACTH/MSH neuropeptides.
    de Wied D
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):353-66. PubMed ID: 1966658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Alzheimer's disease with a synthetic ACTH 4-9 analog.
    Soininen H; Koskinen T; Helkala EL; Pigache R; Riekkinen PJ
    Neurology; 1985 Sep; 35(9):1348-51. PubMed ID: 2991817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of a behaviorally highly potent ACTH4-9 analog in rat brain after intraventricular administration.
    Verhoef J; Palkovits M; Witter A
    Brain Res; 1977 Apr; 126(1):89-104. PubMed ID: 192419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and 11C-labelling of the ACTH fragment analogue H-Met(O2)-Glu-His-Phe-D-Lys-Phe-OH (Org 2766) via its homocystine-containing precursor.
    van Nispen JW; Janssen WP; Melgers PA; Janssen PS; Jansen JF; Vaalburg W
    Int J Pept Protein Res; 1990 Aug; 36(2):167-72. PubMed ID: 1980269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurotrophic analogue of ACTH(4-9), Org 2766, protects against experimental allergic neuritis.
    Duckers HJ; Verhaagen J; Gispen WH
    Brain; 1993 Oct; 116 ( Pt 5)():1059-75. PubMed ID: 8221047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does an ACTH derivative (Org 2766) prevent deterioration of EEG in Alzheimer's disease?
    Partanen JV; Soininen H; Riekkinen PJ
    Electroencephalogr Clin Neurophysiol; 1986 Jun; 63(6):547-51. PubMed ID: 2422004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACTH 4-10 in the amelioration of neuropsychological symptomatology associated with senile organic brain syndrome.
    Branconnier RJ; Cole JO; Gardos G
    Psychopharmacology (Berl); 1979 Mar; 61(2):161-5. PubMed ID: 220656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in muscle action potentials of patients with diseases of motor units following the infusion of a peptide fragment of ACTH.
    Strand FL; Stoboy H; Friedebold G; Krivoy W; Heyck H; van Riezen H
    Arzneimittelforschung; 1977; 27(3):681-3. PubMed ID: 194605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single injection of a biodegradable microsphere formulation of the ACTH-(4-9) analogue ORG 2766 accelerates functional recovery after brain damage.
    Wolterink G; Bouwman TR; Eenink MJ; De Nijs H; van Ree JM
    J Pharm Pharmacol; 1990 Jul; 42(7):508-10. PubMed ID: 1980295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial with ORG 2766, an ACTH-(4-9) analog, in 50 relatively able children with autism.
    Buitelaar JK; Dekker ME; van Ree JM; van Engeland H
    Eur Neuropsychopharmacol; 1996 Mar; 6(1):13-9. PubMed ID: 8866933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The enhanced recovery of sensorimotor function in rats is related to the melanotropic moiety of ACTH/MSH neuropeptides.
    Bijlsma WA; Schotman P; Jennekens FG; Gispen WH; De Wied D
    Eur J Pharmacol; 1983 Sep; 92(3-4):231-6. PubMed ID: 6313395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone-insensitive facilitation and naltrexone-sensitive inhibition of passive avoidance behavior of the ACTH-(4-9) analog (ORG 2766) are located in two different parts of the molecule.
    Fekete M; De Wied D
    Eur J Pharmacol; 1982 Jul; 81(3):441-8. PubMed ID: 6288413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of amnesia by an orally active ACTH 4-9 analog (Org 2766).
    Rigter H; Janssens-Elbertse R; Van Riezen H
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):53-8. PubMed ID: 189332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial of an ACTH4-9 Analogue (ORG 2766) in children with intractable seizures.
    Pentella K; Bachman DS; Sandman CA
    Neuropediatrics; 1982 May; 13(2):59-62. PubMed ID: 6290927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for the use of the ACTH4-9 analogue ORG 2766 in the treatment of diabetic neuropathy.
    Bravenboer B; Erkelens DW; Gispen WH
    Neth J Med; 1992 Dec; 41(5-6):255-8. PubMed ID: 1337372
    [No Abstract]   [Full Text] [Related]  

  • 20. The ACTH (4-9) analog ORG 2766 in panic disorder: a preliminary study.
    den Boer JA; Westenberg HG; Mastenbroek B; van Ree JM
    Psychopharmacol Bull; 1989; 25(2):204-8. PubMed ID: 2557650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.